Bone Histomorphometric Evaluation of Pamidronate Treatment in Clinically Manifest Osteoporosis

Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units

1987 • 3,281 citations

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

1995 • 2,293 citations

Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis

1990 • 949 citations

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.

1997 • 527 citations

PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)

1988 • 342 citations

FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE

1984 • 202 citations

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1993 • 160 citations

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study

1995 • 157 citations

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

1989 • 148 citations

Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.

1994 • 133 citations

The use of bisphosphonates in the treatment of osteoporosis

1992 • 110 citations

Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis.

1994 • 47 citations

An Improved Method for Embedding Hard Tissue in Poeymethyl Methacrylate

1983 • 40 citations

Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.

1995 • 35 citations